Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Operating Income (2020 - 2026)

Biomea Fusion (BMEA) posted Operating Income of -$12.8 million for Q1 2026, down 9.0% sequentially from -$11.7 million in Q4 2025, and up 57.01% YoY from -$8.1 million in Q1 2025.

Biomea Fusion (BMEA) Operating Income (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Operating Income for 7 years, with the latest figure at -$12.8 million in Q1 2026.

  • Quarterly Operating Income rose 57.01% year-over-year to -$12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.6 million (up 49.84% YoY) and the FY2025 annual result came in at -$83.5 million, up 42.03% from the prior year.
  • Operating Income fell to -$12.8 million in Q1 2026 per BMEA's latest filing, from -$11.7 million in the prior quarter.
  • Over five years, Operating Income peaked at -$11.7 million in Q4 2025 and troughed at -$41.1 million in Q1 2024.
  • A 5-year average of -$26.5 million and a median of -$27.7 million in 2023 frame the typical range for Operating Income.
  • The sharpest annual moves came in 2022 and 2025: Operating Income tumbled 180.01% in 2022, then soared 61.03% in 2025.
  • Over 5 years, Operating Income stood at -$26.3 million in 2022, then sank by 42.06% to -$37.3 million in 2023, then climbed by 19.43% to -$30.1 million in 2024, then jumped by 61.03% to -$11.7 million in 2025, then retreated by 9.0% to -$12.8 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$12.8 million, -$11.7 million, and -$20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -815.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 325.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 231.44 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -375.75 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.55 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 133.12 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -12.77 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.77 Mn
Mar 31, 2026 -12.77 Mn
Dec 31, 2025 -11.72 Mn
Sep 30, 2025 -20.81 Mn
Jun 30, 2025 -21.28 Mn
Mar 31, 2025 -29.71 Mn
Dec 31, 2024 -30.07 Mn
Sep 30, 2024 -34.04 Mn
Jun 30, 2024 -38.90 Mn
Mar 31, 2024 -41.06 Mn
Dec 31, 2023 -37.33 Mn
Sep 30, 2023 -31.12 Mn
Jun 30, 2023 -27.66 Mn
Mar 31, 2023 -30.03 Mn
Dec 31, 2022 -26.28 Mn
Sep 30, 2022 -23.48 Mn
Jun 30, 2022 -17.47 Mn
Mar 31, 2022 -16.40 Mn
Dec 31, 2021 -14.74 Mn
Sep 30, 2021 -12.64 Mn